307 related articles for article (PubMed ID: 23012326)
1. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.
Perales MA; Goldberg JD; Yuan J; Koehne G; Lechner L; Papadopoulos EB; Young JW; Jakubowski AA; Zaidi B; Gallardo H; Liu C; Rasalan T; Wolchok JD; Croughs T; Morre M; Devlin SM; van den Brink MR
Blood; 2012 Dec; 120(24):4882-91. PubMed ID: 23012326
[TBL] [Abstract][Full Text] [Related]
2. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
Front Immunol; 2019; 10():334. PubMed ID: 30894856
[TBL] [Abstract][Full Text] [Related]
3. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.
Sereti I; Dunham RM; Spritzler J; Aga E; Proschan MA; Medvik K; Battaglia CA; Landay AL; Pahwa S; Fischl MA; Asmuth DM; Tenorio AR; Altman JD; Fox L; Moir S; Malaspina A; Morre M; Buffet R; Silvestri G; Lederman MM;
Blood; 2009 Jun; 113(25):6304-14. PubMed ID: 19380868
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation.
van Heijst JW; Ceberio I; Lipuma LB; Samilo DW; Wasilewski GD; Gonzales AM; Nieves JL; van den Brink MR; Perales MA; Pamer EG
Nat Med; 2013 Mar; 19(3):372-7. PubMed ID: 23435170
[TBL] [Abstract][Full Text] [Related]
5. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
[TBL] [Abstract][Full Text] [Related]
6. T Cell and Cytokine Dynamics in the Blood of Patients after Hematopoietic Stem Cell Transplantation and Multipotent Mesenchymal Stromal Cell Administration.
Petinati N; Davydova Y; Nikiforova K; Bigildeev A; Belyavsky A; Arapidi G; Drize N; Kuzmina L; Parovichnikova E; Savchenko V
Transplant Cell Ther; 2023 Feb; 29(2):109.e1-109.e10. PubMed ID: 36372356
[TBL] [Abstract][Full Text] [Related]
7. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.
Francois B; Jeannet R; Daix T; Walton AH; Shotwell MS; Unsinger J; Monneret G; Rimmelé T; Blood T; Morre M; Gregoire A; Mayo GA; Blood J; Durum SK; Sherwood ER; Hotchkiss RS
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515037
[TBL] [Abstract][Full Text] [Related]
9. Frequency analysis of TRBV subfamily sjTRECs to characterize T-cell reconstitution in acute leukemia patients after allogeneic hematopoietic stem cell transplantation.
Wu X; Zhu K; Du X; Chen S; Yang L; Wu J; Liu Q; Li Y
J Hematol Oncol; 2011 Apr; 4():19. PubMed ID: 21513557
[TBL] [Abstract][Full Text] [Related]
10. HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion.
Stevanovic S; van Bergen CA; van Luxemburg-Heijs SA; van der Zouwen B; Jordanova ES; Kruisselbrink AB; van de Meent M; Harskamp JC; Claas FH; Marijt EW; Zwaginga JJ; Halkes CJ; Jedema I; Griffioen M; Falkenburg JH
Blood; 2013 Sep; 122(11):1963-73. PubMed ID: 23777765
[TBL] [Abstract][Full Text] [Related]
11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
12. Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant.
Goldberg JD; Zheng J; Ratan R; Small TN; Lai KC; Boulad F; Castro-Malaspina H; Giralt SA; Jakubowski AA; Kernan NA; O'Reilly RJ; Papadopoulos EB; Young JW; van den Brink MR; Heller G; Perales MA
Leuk Lymphoma; 2017 Aug; 58(8):1859-1871. PubMed ID: 28073320
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.
Gabanti E; Lilleri D; Ripamonti F; Bruno F; Zelini P; Furione M; Colombo AA; Alessandrino EP; Gerna G
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2192-2202. PubMed ID: 26260678
[TBL] [Abstract][Full Text] [Related]
14. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
Matsuoka K; Kim HT; McDonough S; Bascug G; Warshauer B; Koreth J; Cutler C; Ho VT; Alyea EP; Antin JH; Soiffer RJ; Ritz J
J Clin Invest; 2010 May; 120(5):1479-93. PubMed ID: 20389017
[TBL] [Abstract][Full Text] [Related]
15. First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation.
Romee R; Cooley S; Berrien-Elliott MM; Westervelt P; Verneris MR; Wagner JE; Weisdorf DJ; Blazar BR; Ustun C; DeFor TE; Vivek S; Peck L; DiPersio JF; Cashen AF; Kyllo R; Musiek A; Schaffer A; Anadkat MJ; Rosman I; Miller D; Egan JO; Jeng EK; Rock A; Wong HC; Fehniger TA; Miller JS
Blood; 2018 Jun; 131(23):2515-2527. PubMed ID: 29463563
[TBL] [Abstract][Full Text] [Related]
16. Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4(+) T Cells after Allogeneic Stem Cell Transplantation.
Gauthier SD; Leboeuf D; Manuguerra-Gagné R; Gaboury L; Guimond M
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1721-31. PubMed ID: 26151303
[TBL] [Abstract][Full Text] [Related]
17. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Du JW; Gu JY; Liu J; Cen XN; Zhang Y; Ou Y; Chu B; Zhu P
Leuk Lymphoma; 2007 Aug; 48(8):1618-27. PubMed ID: 17701594
[TBL] [Abstract][Full Text] [Related]
18. PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
Hossain MS; Kunter GM; El-Najjar VF; Jaye DL; Al-Kadhimi Z; Taofeek OK; Li JM; Waller EK
PLoS One; 2017; 12(9):e0184254. PubMed ID: 28953925
[TBL] [Abstract][Full Text] [Related]
19. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
[TBL] [Abstract][Full Text] [Related]
20. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
Servais S; Lengline E; Porcher R; Carmagnat M; Peffault de Latour R; Robin M; Sicre de Fontebrune F; Clave E; Maki G; Granier C; Xhaard A; Dhedin N; Molina JM; Toubert A; Moins-Teisserenc H; Socie G
Biol Blood Marrow Transplant; 2014 Apr; 20(4):507-17. PubMed ID: 24406505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
